Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aeroasis is a Santa Cruz, California startup focused on smart indoor growing systems and UVC-based risk mitigation tools rather than therapeutics or drug development. The company was founded in 2015 by Thomas Wollenberger and initially developed automated hydroponic smart garden products for home and hyper-local food production. It later expanded into germicidal UVC products intended to reduce pathogenic and fungal risk around plants and people. Publicly available information describes Aeroasis as an agtech, IoT, robotics, and product-development company with commercial products including smart garden systems and UVC devices. Based on the available evidence, it is not a life sciences, biotech, pharma, or healthcare company in the conventional industry sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aeroasis.